Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.
Shandong Xinhua Pharmaceutical Company Limited has announced proposed amendments to its Articles of Association to comply with new regulatory requirements in China. These changes include abolishing the Supervisory Committee, transferring its functions to the Audit Committee, adjusting powers of the Shareholders’ meeting and the Board, and revising the business scope description. The amendments are subject to shareholder approval at a general meeting.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 8,369,606
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.52B
For a thorough assessment of 0719 stock, go to TipRanks’ Stock Analysis page.